| # | Drug | Count |
|---|---|---|
| 0 | LENALIDOMIDE | 11 |
| 1 | MELPHALAN | 11 |
| 2 | MELPHALAN HYDROCHLORIDE | 11 |
| 3 | POMALIDOMIDE | 10 |
| 4 | CILTACABTAGENE AUTOLEUCEL | 6 |
| 5 | IDECABTAGENE VICLEUCEL | 5 |
| 6 | OLAPARIB | 2 |
| 7 | RITUXIMAB | 2 |
| 8 | AMLODIPINE BESYLATE | 1 |
| 9 | AXICABTAGENE CILOLEUCEL | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IDECABTAGENE VICLEUCEL | 5 | 0.0040 |
| 1 | CILTACABTAGENE AUTOLEUCEL | 6 | 0.0009 |
| 2 | BREXUCABTAGENE AUTOLEUCEL | 1 | 0.0005 |
| 3 | MELPHALAN HYDROCHLORIDE | 11 | 0.0004 |
| 4 | LUSPATERCEPT | 1 | 0.0004 |
| 5 | AXICABTAGENE CILOLEUCEL | 1 | 0.0001 |
| 6 | POMALIDOMIDE | 10 | 0.0001 |
| 7 | OLAPARIB | 2 | 0.0001 |
| 8 | FAM-TRASTUZUMAB DERUXTECAN-NXKI | 1 | 0.0001 |
| 9 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Erythroid Maturation Agent [EPC] | 1 | 0.0004 |
| 1 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 2 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 4 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 5 | Thalidomide Analog [EPC] | 11 | 0.0000 |
| 6 | Erythropoiesis-stimulating Agent [EPC] | 1 | 0.0000 |
| 7 | Purine Antimetabolite [EPC] | 1 | 0.0000 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 2 | 0.0000 |
| 9 | Thiazide Diuretic [EPC] | 1 | 0.0000 |